Strengthen your advocacy skills ahead of #IDWeek2026. Join IDSA and HIVMA for the IDWeek Advocacy Lab, an interactive advocacy training, next Tuesday, Oct. 20 at 4pm ET.

Learn more and register: https://bit.ly/4rmGy1A

October 15 is National Latinx AIDS Awareness Day, a time to raise awareness of HIV’s disproportionate impact on Hispanic/Latinx communities, promote HIV testing and help end HIV stigma.

Learn more this #NLAAD: https://bit.ly/47hSoRF

Join “Your Voice, Your Patients, Your Community: ID and HIV Advocacy in an Election Year” at #IDWeek2026 to hear from HIVMA advocates about engaging Congress on key ID/HIV priorities and learn how the 2026 midterm elections could shape the future.

RSVP: https://bit.ly/4rVsL2t

How is HIV treatment evolving, and what will shape its future?

Join the #IDWeek2026 session, “State-of-the-Art HIV Treatment” to explore new ART regimens, emerging therapies and strategies to sustain global HIV progress.

Register for IDWeek: https://www.idweek.org/registration/

On #NationalPrEPDay, we’re highlighting a powerful tool in HIV prevention. PrEP is highly effective at preventing HIV, yet access remains inequitable. We must continue working to make PrEP accessible, affordable and stigma-free for everyone.

Learn more: https://bit.ly/4dwq4yn

Join “Your Voice, Your Patients, Your Community: ID and HIV Advocacy in an Election Year” at #IDWeek2026 to hear from HIVMA advocates about engaging Congress on key ID and HIV priorities and learn how the 2026 midterm elections could shape the future.

RSVP here: https://bit.ly/4rVsL2t

What do you do when HIV cases don’t have easy answers?

Join the #IDWeek2026 session, “Challenging HIV Treatment and Prevention Clinical Cases” to work through cases involving antiretroviral resistance, drug interactions, treatment failure and more.

Register: https://www.idweek.org/registration/

Delays in renewing federal funding for four major HIV research networks raise concerns about the future of critical HIV clinical trials and research. https://nyti.ms/4hLFMXL

Our recent press briefing explores how federal funding delays could impact scientific progress: https://bit.ly/4h5UQAp

The Panel on Antiretroviral Guidelines for Adults and Adolescents updated the HIV treatment guidelines on Sept. 24, with revisions covering What to Start, Optimizing Antiretroviral Therapy, Adolescents and Young Adults With HIV, Substance Use Disorders, Women With HIV & more. https://bit.ly/4je6gRB

Help shape the future of HCV screening coverage.

CMS is reviewing Medicare’s coverage of HCV screening for adults ages 18–79 and seeking input on screening intervals and screening in non-primary care settings.

Learn more and submit your comments by Oct. 23: https://go.cms.gov/4dinPP6

Explore the connections between HIV, STIs and substance use disorders at #IDWeek2026. Join “A Syndemic Approach: Great Cases in HIV, STIs and Substance Use Disorders” for a case-based look at these intersecting areas of care.

Learn more and register for IDWeek: https://cdmcd.co/GwYAyX

HIV clinical research infrastructure doesn't happen overnight. IDSA CEO Jeanne Marrazzo, MD, MPH, FIDSA, explains why the networks that have supported decades of HIV research and discovery must be protected.
 
Watch the full press briefing:
bit.ly/4h5UQAp

Today marks National Gay Men’s HIV/AIDS Awareness Day, an opportunity to raise awareness about the disproportionate impact of HIV on gay and bisexual men and work toward ending HIV stigma.

Learn more this #NGMHAAD: https://bit.ly/4xO6Yen

Early career HIV researchers: Join the NIH Office of AIDS Research and partners on Sept. 28 for the fifth annual Workshop for Early Career Investigators in HIV. Hear about funding opportunities, OAR priorities, mentorship, career development and more.

Learn more & register: https://bit.ly/4xDw54k

HIV treatment has come a long way, but important questions remain. IDSA spokesperson and HIV researcher, Aadia Rana, MD, FIDSA (@aadiamd.bsky.social) explains what researchers are working to understand next.

Watch the full press briefing: https://bit.ly/4h5UQAp

🚨 New resource for healthcare providers! CDC’s free Syphilis Tools app offers an interactive clinical reference to support syphilis screening, testing and treatment.

Download the app or access the progressive web app: https://bit.ly/4rEXjp1

This week, @lambdalegal.org & HIV advocates brought the case for equitable care into the courtroom.

See comments from HIVMA Past Chair Melanie Thompson, MD, on protecting access to comprehensive care, including gender-affirming care, for transgender PWH through Ryan White: bit.ly/4yZB0wQ

Progress toward ending the U.S. HIV epidemic is measurable, but it is not shared equally. The latest AIDSVu data highlight improvements in HIV diagnoses, care outcomes and PrEP use while underscoring persistent disparities in prevention access and HIV burden.

Learn more: https://bit.ly/3V7OCHG

HIV treatment has transformed millions of lives, but much work remains. HIVMA board member Carlos Malvestutto, MD, MPH, FIDSA, explains why continued investment in HIV research is essential to protecting progress and advancing new treatments.

Watch: https://bit.ly/4h5UQAp

What happens to patients when HIV clinical trial funding is delayed? IDSA spokesperson and HIV researcher, Aadia Rana, MD, FIDSA (@aadiamd.bsky.social) explains how the effects can be felt immediately.

Watch the full press briefing: https://bit.ly/4h5UQAp